Furthermore, IL-35 may play a role in osteoclasts induced by RANKL and M-CSF via the Th17/IL-17 axis, exhibiting inhibitory effects on both metabolic processes associated with osteoporosis [231,232,233]. This evidence concerns the gene TNFSF11 and osteoporosis.